Fibroblast growth factor 9 (FGF9)‐mediated neurodegeneration: Implications for progressive multiple sclerosis?

Katja Thümmler(Institute of Infection and Immunity), Christopher Linington(Centre for Immunity, Infection and Evolution), Diana Arseni(MRC Laboratory of Molecular Biology), Christine Stadelmann(Universitätsmedizin Göttingen), Lorna Hayden(University of Glasgow), Friedrich Schwarz(Universitätsmedizin Göttingen), Sebastian Kügler(Universitätsmedizin Göttingen), Claudia Wrzos(Universitätsmedizin Göttingen), Andreas Junker(University of Duisburg-Essen), Fred Wolf(Max Planck Institute for Dynamics and Self-Organization), Andreas Neef(Max Planck Institute for Dynamics and Self-Organization), Jonas Franz(Boston University), John Cole(University of Glasgow), Daniel McElroy(University of Glasgow), Julia M. Edgar(Institute of Infection and Immunity)

Neuropathology and Applied Neurobiology

September 14, 2023

Cited by 7

|Frontiers in Molecular Neuroscience|2013|753

|The Lancet Neurology|2021|518

|Brain Pathology|2008|479

|UCL Discovery (University College London)|2022|422

|Acta Neuropathologica|2009|329

Related Papers